User uShare Login | Register
Login
Register

Along with posting photos, videos, and stories, your uShare account lets you post Classified Ads, recipes on What's For Dinner, and Announcements.


42° View Weather Current Conditions Sioux Falls Change Location
Set Weather Options

RADAR LOCATION

TEMPERATURE LOCATION

News

[0] My Saved Articles
Back to all news

Business

Find local businesses
on the KELO Pages!

 

Most Popular Today


Sanford Research Secures Two NIH Grants

August 28, 2013, 2:08 PM

Sanford Research Secures Two NIH Grants
SIOUX FALLS, SD -

A pair from Sanford Research has received separate grants from the National Institutes of Health (NIH) totaling more than $2.6 million for studies involving genomic proteins and a cancer-killing drug.

Kyle J. Roux, PhD, earned a five-year, $1.52 million award from the NIH’s National Institute of General Medical Sciences (NIGMS) for his project titled “Developing methods for proximity-dependent protein labeling.”

Keith Miskimins, PhD, and his study, “Molecular mechanisms by which the diabetic drug metformin kills cancer cells,” will receive more than $1.18 million over four years from the NIH’s National Cancer Institute (NCI).

Last year, Dr. Roux unveiled a new way to identify the proximity and interactions between proteins in living cells called BioID.  The system provides insight into the underlying mechanisms of disease. His grant will allow him to further develop BioID and advance the rate at which scientists characterize proteins and their interactions, which helps in the design of therapies for human disease.

“With the human genome sequenced, we have now shifted our attention toward the challenging task of characterizing the protein products of that genome,” said Dr. Roux. “The results of this study will provide the research community with the fundamental knowledge of the capabilities of BioID.”

Dr. Miskimins’ study will explore the molecular and cellular mechanisms by which metformin, a drug used to treat type 2 diabetes, kills cancer cells. In cultured cells and animal models, metformin has been found to kill cancer cells and slow tumor growth, but the drug behaves differently when other compounds are present or nutrient availability changes.

“We want to understand how the combinations of other compounds and nutrients affect cancer cells at the molecular level and provide a rationale for how they might be used clinically,” said Dr. Miskimins. “While this study will primarily focus on breast cancer, the results could be applicable to many types of cancer.”

This is the third NIH grant for Sanford Research this summer.  In July, Michael Kruer, MD, a Sanford pediatric neurologist and neurogeneticist, was awarded $860,000 in NIH funding to further genetic research on juvenile Parkinson's disease and dystonia.

The NIH, a part of the U.S. Department of Health and Human Services Policy, is the nation’s medical research agency.

Disclaimer: This story has been reviewed but not edited or fact-checked. Views of the author are not necessarily those of this station, its owners, officers, agents or employees.

 

Previous Story

Next Story




 
Find Local Businesses on KELO Pages!

View business

You may also like

New Indoor Racing & Recreation Business

11/19/2014 10:05 PM

For about four months out of the year, people in the Sioux Falls area can go go-kart racing and play mini golf.

Full Story | Watch
New Sioux Falls Shop Opens Thursday

11/19/2014 11:10 AM

Holiday shoppers will soon have a new spot to buy locally made gifts.

Full Story
Stroller Recall Due To Amputation Hazard

11/20/2014 9:45 AM

More than four million strollers sold in the United States are part of a recall.

Full Story
Alco To Close Stores Across South Dakota

11/21/2014 2:03 PM

Several South Dakota cities will soon have one less store.

Full Story
Gas Stations In Region Struggling To Keep Up Supply

11/18/2014 5:52 PM

Over the past few days, drivers in Sioux Falls have been noticing certain grades of fuel are out of stock at gas stations across town.

Full Story | Watch


Events